These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 28676386)

  • 1. Prodrugs in medicinal chemistry and enzyme prodrug therapies.
    Walther R; Rautio J; Zelikin AN
    Adv Drug Deliv Rev; 2017 Sep; 118():65-77. PubMed ID: 28676386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substrate mediated enzyme prodrug therapy.
    Fejerskov B; Jarlstad Olesen MT; Zelikin AN
    Adv Drug Deliv Rev; 2017 Sep; 118():24-34. PubMed ID: 28457884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prodrug applications for targeted cancer therapy.
    Giang I; Boland EL; Poon GM
    AAPS J; 2014 Sep; 16(5):899-913. PubMed ID: 25004822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Designing metal-contained enzyme mimics for prodrug activation.
    Du B; Li D; Wang J; Wang E
    Adv Drug Deliv Rev; 2017 Sep; 118():78-93. PubMed ID: 28412325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-immolative nitrogen mustard prodrugs for suicide gene therapy.
    Niculescu-Duvaz D; Niculescu-Duvaz I; Friedlos F; Martin J; Spooner R; Davies L; Marais R; Springer CJ
    J Med Chem; 1998 Dec; 41(26):5297-309. PubMed ID: 9857097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-Immolative Linkers Literally Bridge Disulfide Chemistry and the Realm of Thiol-Free Drugs.
    Riber CF; Smith AA; Zelikin AN
    Adv Healthc Mater; 2015 Aug; 4(12):1887-90. PubMed ID: 26109168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted enzyme prodrug therapies.
    Schellmann N; Deckert PM; Bachran D; Fuchs H; Bachran C
    Mini Rev Med Chem; 2010 Sep; 10(10):887-904. PubMed ID: 20560876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceria Nanozyme and Phosphate Prodrugs: Drug Synthesis through Enzyme Mimicry.
    Walther R; Huynh TH; Monge P; Fruergaard AS; Mamakhel A; Zelikin AN
    ACS Appl Mater Interfaces; 2021 Jun; 13(22):25685-25693. PubMed ID: 34033459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of self-immolative linkers for tumour-activated prodrug therapy.
    Tranoy-Opalinski I; Fernandes A; Thomas M; Gesson JP; Papot S
    Anticancer Agents Med Chem; 2008 Aug; 8(6):618-37. PubMed ID: 18690826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smart nanocarriers for enzyme-activated prodrug therapy.
    Abo Qoura L; Morozova E; Ramaa СS; Pokrovsky VS
    J Drug Target; 2024 Nov; 32(9):1029-1051. PubMed ID: 39045650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of prodrugs for enzyme-mediated, tumor-selective therapy.
    Yoon KJ; Potter PM; Danks MK
    Curr Med Chem Anticancer Agents; 2005 Mar; 5(2):107-13. PubMed ID: 15777218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-immolative Linkers in Prodrugs and Antibody Drug Conjugates in Cancer Treatment.
    Edupuganti VVSR; Tyndall JDATDA; Gamble AB
    Recent Pat Anticancer Drug Discov; 2021; 16(4):479-497. PubMed ID: 33966624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Designer bacteria as intratumoural enzyme biofactories.
    Lehouritis P; Hogan G; Tangney M
    Adv Drug Deliv Rev; 2017 Sep; 118():8-23. PubMed ID: 28916496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physicochemical property trends of marketed prodrugs.
    Landis MS
    Ther Deliv; 2013 Feb; 4(2):225-37. PubMed ID: 23343161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prodrugs--from serendipity to rational design.
    Huttunen KM; Raunio H; Rautio J
    Pharmacol Rev; 2011 Sep; 63(3):750-71. PubMed ID: 21737530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A self-immolative prodrug nanosystem capable of releasing a drug and a NIR reporter for in vivo imaging and therapy.
    Wang Z; Wu H; Liu P; Zeng F; Wu S
    Biomaterials; 2017 Sep; 139():139-150. PubMed ID: 28614754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What should be considered on design of a colon-specific prodrug?
    Jung Y; Kim YM
    Expert Opin Drug Deliv; 2010 Feb; 7(2):245-58. PubMed ID: 20095945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of human, rat and mouse hydrolyzing enzymes bioconverting amino acid ester prodrug of ketoprofen.
    Huttunen KM
    Bioorg Chem; 2018 Dec; 81():494-503. PubMed ID: 30243240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective activation of anthracycline prodrugs for use in conjunction with ADEPT.
    HariKrishna D; Rao AR; Krishna DR
    Drug News Perspect; 2003 Jun; 16(5):309-18. PubMed ID: 12942162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted prodrug design to optimize drug delivery.
    Han HK; Amidon GL
    AAPS PharmSci; 2000; 2(1):E6. PubMed ID: 11741222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.